Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

50,467

285

300

Ganymed Pharmaceuticals

Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.

Acquired by Astellas Pharma on October 28, 2016

Founded: January 01, 2001

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...
NeuroX1	Pharmaceuticals & Biotechnology	The new standard in computational neuroscience - NeuroX1 is a computational drug design company bui ...

View more competitors»

Date	Round	Amount	Investors
Nov 18, 2013	Series E	€ 45,000,000	Future Capital AG MIG AG ATS Beteiligungsverwaltung FCPB
Nov 19, 2008	Venture	€ 65,000,000	Future Capital AG MIG AG ATS Beteiligungsverwaltung
Sep 24, 2007	Series C	€ 37,200,000	ATS Beteiligungsverwaltung VI Partners Landesbank Baden Württemberg Future Capital AG

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
Christoph Huber	Founder	Unknown to Unknown